Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore tax-efficient passive income sources in retirement and how different streams affect taxes, ensuring you optimize withdrawals and eligibility.
24,018 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
I recently allocated just more than $10,000 across three tech stocks to balance growth with risk. Here’s how I chose ...
The VIX nears the 30 threshold as geopolitical tensions and energy prices spike risk. Markets brace for a choppier we...
BlackRock's tokenized BUIDL fund will publish continuous on-chain attestations to back holdings, valuation, and custo...
Aave asks a New York court to lift a restraining order on ETH set aside for victims of a DeFi breach, arguing the ass...
Benutech launches SellScore and RefiScore to help real estate agents and mortgage lenders target high-potential homeo...
A wave of AI compute demand is reshaping the chip landscape. While Cerebras eyes an IPO, the market shows that strong...
Korea's top exchanges show XRP eclipsing Bitcoin in 24-hour volume as local retail traders bet on high-volatility coi...
Dell Technologies rides a booming AI infrastructure cycle into 2027, with a record AI backlog and ambitious revenue t...
NextEra Energy is pursuing a $67 billion all-stock deal to buy Dominion, aiming to create the world’s largest utility...
A rapid AI-driven capex cycle is widening the performance split between cap-weighted and equal-weight NASDAQ funds, u...
A high-stakes dispute between MRED and Zillow has led to tens of thousands of Chicago listings being pulled from Zill...